<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=489233&amp;fmt=gif">

Scilife appoints Sebastien Sepierre as new CEO

Scilife announces that Sebastien Sepierre will take the helm as the new CEO, effective immediately. He succeeds Filip Heitbrink, who will remain on Scilife's Board of Directors.

Sebastien Sepierre as new CEO of Scilife

General
Press Release

Scilife

09.02.2024

ANTWERP, BELGIUM, Sep 02, 2024— Scilife announced today that Sebastien Sepierre has been appointed as the new CEO of the company. An experienced business leader, Sepierre will succeed Filip Heitbrink and assume responsibilities immediately. Filip will continue to serve as a member of Scilife's Board of Directors.

Sebastien Sepierre brings over 20 years of experience in the software as a service (SaaS) industry. He previously served as the Managing Director for Fourth,  a workforce management software company where he joined in 2017 as Vice President of Operations and has been a key member of the leadership team.

 

"We are thrilled to welcome Sebastien as our new CEO. Scilife needs a leader to propel growth, and we believe Sebastien is uniquely qualified to take on this role at this pivotal time in the company," said Filip Heitbrink, former CEO and board member. "His track record of success and deep understanding of the SaaS landscape will be invaluable as we enter our next phase of expansion and innovation," commented Filip. 

 

During his tenure at Fourth, Sepierre demonstrated exceptional leadership and contributed significantly to the company's success in the EMEA region. His expertise in local markets and operational management has been instrumental in driving growth and improving customer satisfaction. Additionally, he spent over five years at IBM, where he held various leadership positions, including Head of Client Services and Implementation and Director of Implementation for the EMEA region.

 

“I am truly honored to step into the role of CEO at a young successful business going through rapid growth,” said Sebastien Seprierre. "Our focus will be on leveraging the industry's best practices to empower our teams and maintain our unique culture, ensuring we continue to build on what makes this company truly exceptional,” announced Sebastien.

 

After securing a strategic growth investment from Five Elms Capital, Scilife's founder and former CEO, Filip Heitbrink, will remain on Scilife's Board of Directors. Since its founding in 2017, Scilife has expanded to serve over 200 customers worldwide, evolving into a 100% remote company with more than 70 employees across the globe—a testament to Heitbrink's leadership excellence.

 

"Sebastien is the ideal candidate for this role. His strategic vision aligns perfectly with our goals of advancing enterprise-wide operational excellence," said Heitbrink. "I'm confident he will make significant contributions to our growth, bolstering Scilife's market presence and accelerating the adoption of our innovative electronic Quality Management System," expressed Filip.

 

As the new CEO, Sebastien will prioritize growth by driving both new customer acquisition and the expansion of existing customer relationships. Furthermore, he will focus on fostering innovation and transforming Scilife into a market-leading QMS provider.

"When Scilife approached me, I immediately connected with the Five Elms team and Filip. It felt like a perfect match in terms of personality and culture. I’m excited to help take Scilife to the next level and continue the journey that Filip started,” commented Sebastien. 

 

 


About Scilife

Founded in 2017, Scilife is a leading quality management solution, providing comprehensive tools to transform quality into a competitive advantage for life sciences. Scilife's Smart Quality framework enables organizations to seamlessly manage their complex workflows, reducing the burden on quality teams and allowing them to focus on driving value.

Trusted by global quality-focused organizations, including Novartis, Biocartis, Yusen Logistics, Polpharma, and Pendulum, Scilife is committed to improving efficiency, simplifying regulatory compliance, and making quality an engaging culture for everyone on board. The impact? Improving patients’ lives.

Join thousands of happy users who are boosting their quality processes with Scilife.

Curious? Click here to learn more about what our smart QMS can do for you.
Scilife-boosts-life-sciences-2